.
MergerLinks Header Logo

Announced

Completed

The Riverside Company completed the investment in Transplant Connect.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Domestic

Health Care Services

healthcare technology

Completed

Friendly

Private Equity

Single Bidder

Minority

medical records

United States

Private

Acquisition

Synopsis

Edit

The Riverside Company, a private equity firm, completed the investment in Transplant Connect, an operator of a cloud-based clinical platform. Financial terms were not disclosed. “Transplant Connect is an excellent addition to the expanding InVita platform as we continue to grow our areas of focus in the healthcare industry. We look forward to supporting the continued growth and innovation of Transplant Connect’s product suite and footprint," Loren Schlachet, Riverside Managing Partner.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US